Brief: Peptonic Medical Q2 Operating Loss Widens To SEK 7.2 Mln
Aug 17 (Reuters) - Peptonic Medical AB PMED.TE :
* Q2 GROSS PROFIT KSEK 2 417 (768)
* Q2 NET SALES SEK 3.6 MILLION VERSUS SEK 1.0 MILLION YEAR
AGO
* Q2 OPERATING LOSS KSEK -7 166 (-5 797)
Source text for Eikon: ID:nWkr2P3vWm
Further company coverage: PMED.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Peptonic Medical AB
See all newsSweden's Peptonic Medical Q2 sales drop, gross margin narrows
Brief: Peptonic Medical Q2 Sales SEK 2.36 Million
Sweden's Peptonic Medical Q1 operating loss narrows on restructuring
Brief: Peptonic Medical Q1 Sales SEK 3.138 Million
Sweden's Peptonic Medical Q4 sales fall, margin improves on restructuring efforts